Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future
- PMID: 26211420
- PMCID: PMC4703452
- DOI: 10.1111/cts.12304
Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future
Abstract
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long-standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5-year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett's esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett's esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett's esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett's carcinogenesis.
Keywords: Barrett's esophagus; animal models; esophageal adenocarcinoma; genetic model; surgical model.
© 2015 Wiley Periodicals, Inc.
Figures

Similar articles
-
Barrett's esophagus and risk of esophageal adenocarcinoma.Semin Gastrointest Dis. 2003 Jul;14(3):128-35. Semin Gastrointest Dis. 2003. PMID: 14653412 Review.
-
Molecular targets for treatment of Barrett's esophagus.Dis Esophagus. 2005;18(2):75-86. doi: 10.1111/j.1442-2050.2005.00465.x. Dis Esophagus. 2005. PMID: 16053481 Review.
-
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.World J Gastroenterol. 2015 May 7;21(17):5210-9. doi: 10.3748/wjg.v21.i17.5210. World J Gastroenterol. 2015. PMID: 25954094 Free PMC article. Review.
-
Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.J Surg Res. 2006 Oct;135(2):337-44. doi: 10.1016/j.jss.2006.04.023. Epub 2006 Aug 22. J Surg Res. 2006. PMID: 16926029
-
The diagnosis and management of Barrett's esophagus.Adv Surg. 1999;33:29-68. Adv Surg. 1999. PMID: 10572561 Review.
Cited by
-
Molecular Profile of Barrett's Esophagus and Gastroesophageal Reflux Disease in the Development of Translational Physiological and Pharmacological Studies.Int J Mol Sci. 2020 Sep 3;21(17):6436. doi: 10.3390/ijms21176436. Int J Mol Sci. 2020. PMID: 32899384 Free PMC article.
-
Bi-layer silk fibroin grafts support functional tissue regeneration in a porcine model of onlay esophagoplasty.J Tissue Eng Regen Med. 2018 Feb;12(2):e894-e904. doi: 10.1002/term.2402. Epub 2017 Jun 20. J Tissue Eng Regen Med. 2018. PMID: 28084044 Free PMC article.
-
Assessment of efficacy and safety of advanced endoscopic irreversible electroporation catheter in the esophagus.Sci Rep. 2023 May 16;13(1):7917. doi: 10.1038/s41598-023-33635-9. Sci Rep. 2023. PMID: 37193702 Free PMC article.
-
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.Int J Mol Sci. 2017 Apr 19;18(4):867. doi: 10.3390/ijms18040867. Int J Mol Sci. 2017. PMID: 28422073 Free PMC article. Review.
-
Non-surgical animal model of gastroesophageal reflux disease by overeating induced in mice.J Investig Med. 2021 Aug;69(6):1208-1214. doi: 10.1136/jim-2020-001691. Epub 2021 Apr 16. J Investig Med. 2021. PMID: 33863754 Free PMC article.
References
-
- Hirst J, Smithers BM, Gotley DC, Thomas J, Barbour A. Defining cure for esophageal cancer: analysis of actual 5‐year survivors following esophagectomy. Ann Surg Oncol. 2011; 18(6): 1766–1774. - PubMed
-
- Phillips WA, Lord RV, Nancarrow DJ, Watson DI, Whiteman DC. Barrett's esophagus. J Gastroenterol Hepatol. 2012; 26(4): 639–648. - PubMed
-
- Grant KS, DeMeester SR, Kreger V, Oh D, Hagen JA, Chandrasoma P, DeMeester TR. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2013; 146(1): 31–37. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous